Transverse leukonychia secondary to paclitaxel-carboplatin chemotherapy in a patient with ovarian cancer. - Suppr | 超能文献

Transverse leukonychia secondary to paclitaxel-carboplatin chemotherapy in a patient with ovarian cancer.

作者信息

Lehoczky O, Pulay T

机构信息

Gynecological Oncology Department, National Institute of Oncology, Budapest, Hungary.

出版信息

J Obstet Gynaecol. 2002 Nov;22(6):694. doi: 10.1080/014436102762062439.

DOI:10.1080/014436102762062439

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Transverse leukonychia secondary to paclitaxel-carboplatin chemotherapy in a patient with ovarian cancer.

J Obstet Gynaecol. 2002 Nov;22(6):694. doi: 10.1080/014436102762062439.

2

[Adverse effect of paclitaxel plus carboplatin combination therapy related to administration schedule in patients with ovarian cancer].[紫杉醇联合卡铂治疗方案给药时间安排与卵巢癌患者不良反应的相关性]

Gan To Kagaku Ryoho. 2001 Sep;28(9):1295-7.

3

Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect.卡铂与紫杉醇联合化疗相关的双侧不可逆性听力损失：一种罕见的副作用。

J Exp Clin Cancer Res. 2003 Mar;22(1):155-8.

4

[Prevention of arthralgia and myalgia from paclitaxel and carboplatin combination chemotherapy with Shakuyaku-kanzo-to].[用芍药甘草汤预防紫杉醇与卡铂联合化疗引起的关节痛和肌痛]

Gan To Kagaku Ryoho. 2000 Jul;27(7):1061-4.

5

Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.妇科肿瘤学 Arbeitsgemeinschaft 卵巢癌研究组的随机研究：比较顺铂/紫杉醇与卡铂/紫杉醇治疗的卵巢癌患者的生活质量。

J Clin Oncol. 2006 Feb 1;24(4):579-86. doi: 10.1200/JCO.2005.02.4067.

6

Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients.老年卵巢癌患者使用低剂量卡铂和紫杉醇进行初始化疗时耐受性得到改善。

Gynecol Oncol. 2008 Apr;109(1):33-8. doi: 10.1016/j.ygyno.2008.01.001. Epub 2008 Feb 7.

7

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.一项关于每周使用卡铂和紫杉醇作为老年晚期卵巢癌患者一线治疗的II期研究。一项意大利卵巢癌多中心试验（MITO-5）研究。

Crit Rev Oncol Hematol. 2008 Jun;66(3):229-36. doi: 10.1016/j.critrevonc.2007.12.005. Epub 2008 Feb 1.

8

Paclitaxel (T) and carboplatin (CB) in ovarian cancer patients in Dharmais National Cancer Hospital, 1993-1999.

Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:560-2.

9

Adverse affects of paclitaxel and carboplatin combination chemotherapy in epithelial gynecologic cancer.紫杉醇与卡铂联合化疗对上皮性妇科癌症的不良影响。

J Med Assoc Thai. 2005 Mar;88(3):301-6.

10

Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer.

J Med Assoc Thai. 2006 Nov;89(11):1805-10.

引用本文的文献

1

Nail Changes With Chemotherapeutic Agents and Targeted Therapies.化疗药物和靶向治疗导致的指甲变化

Indian Dermatol Online J. 2022 Jan 24;13(1):13-22. doi: 10.4103/idoj.IDOJ_801_20. eCollection 2022 Jan-Feb.

2

Nail change after chemotherapy: simultaneous development of Beau's lines and Mees' lines.化疗后的指甲变化：博氏线与米氏线同时出现。

Ann Dermatol. 2012 May;24(2):238-9. doi: 10.5021/ad.2012.24.2.238. Epub 2012 Apr 26.